Peptide Based Infection Therapeutics
The affected population is currently developing antibiotic resistance due to the excessive and inappropriate usage of antibiotics. Consequently, there is a growing need to create novel medicines to combat infections. In terms of stability, safety, tolerance, selectivity, efficacy with a wide range of actions and mechanisms, new, Peptide Based Infection Therapeutics medicines have brought a number of benefits. They are also known as host defence peptides because they shield the host from pathogenic microorganisms.
Drugs Type-
· Telaprevir
· Boceprevir
